Distinct Sites for Inverse Modulation ofN-Methyl-d-Aspartate Receptors by Sulfated Steroids

Abstract

Steroid sulfation occurs in nervous tissue and endogenous sulfated steroids can act as positive or negative modulators ofN-methyl-d-aspartate (NMDA) receptor function. In the current study, structure-activity relationships for sulfated steroids were examined in voltage-clamped chick spinal cord and rat hippocampal neurons in culture and in Xenopus laevis oocytes expressing NR1100 and NR2A subunits. The ability of pregnenolone sulfate (a positive modulator) and epipregnanolone sulfate (a negative modulator) to compete with each another, as well as with other known classes of NMDA receptor modulators, was examined. The results show that steroid positive and negative modulators act at specific, extracellularly directed sites that are distinct from one another and from the spermine, redox, glycine, Mg2+, MK-801, and arachidonic acid sites. Sulfated steroids are effective as modulators of ongoing glutamate-mediated synaptic transmission, which is consistent with their possible role as endogenous neuromodulators in the CNS.

Footnotes

  • Send reprint requests to: Dr. David H. Farb, Department of Pharmacology, Boston University, School of Medicine, 80 East Concord Street, Boston, MA 02118.

  • 1 Current affiliation: Gene Therapy Unit, Laboratory of Molecular Cell Biology, Institute of Bioscience and Biotechnology, Yasong, Taejon, Korea.

  • 2 Current affiliation: Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan 70101, Republic of China

  • This work was supported by National Institute of Mental Health Grant MH49469.

  • Abbreviations:
    NMDA
    N-methyl-d-aspartate
    DHEAS
    dehydroepiandrosterone sulfate
    PS
    pregnenolone sulfate
    3β5βS
    3β-hydroxy-5β-pregnan-20-one sulfate
    AMPA
    α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
    EPSC
    spontaneous excitatory postsynaptic current
    ara-C
    1-β-d-arabinofuranosylcytosine
    PHS
    pregnenolone hemisuccinate
    EGTA
    ethylene glycol bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
    HEPES
    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
    DTT
    dithiothreitol
    NEM
    N-ethylmaleimide
    APV
    (±)-2-amino-5-phosphonopentanoic acid
    3α5βS
    3α-hydroxy-5β-pregnan-20-one sulfate
    3β5αS
    3β-hydroxy-5α-pregnan-20-one sulfate
    3α5αS
    3α-hydroxy-5α-pregnan-20-one sulfate
    • Received March 3, 1997.
    • Accepted August 12, 1997.
« Previous | Next Article »Table of Contents